SLC2A10 Antikörper (AA 288-335) (Biotin)

Produktnummer ABIN899083

Produktdetails anti-SLC2A10 Antikörper (Biotin)

Target: SLC2A10 (Solute Carrier Family 2 (Facilitated Glucose Transporter), Member 10 (SLC2A10))

Bindungsspezifität: AA 288-335

Reaktivität: Ratte

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser SLC2A10 Antikörper ist konjugiert mit Biotin

Applikation: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Kreuzreaktivität: Ratte

Homologie: Human,Mouse,Dog,Cow

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human GLUT10

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C for 12 months.

Haltbarkeit: 12 months

Details zu SLC2A10

Target: SLC2A10 (Solute Carrier Family 2 (Facilitated Glucose Transporter), Member 10 (SLC2A10))

Andere Bezeichnung: GLUT10 (SLC2A10 Produkte)

Synonyme: SLC2A10 antikoerper, zgc:171488 antikoerper, ATS antikoerper, GLUT10 antikoerper, AA450473 antikoerper, Glut10 antikoerper, solute carrier family 2 member 10 antikoerper, solute carrier family 2 (facilitated glucose transporter), member 10 antikoerper, SLC2A10 antikoerper, slc2a10 antikoerper, Slc2a10 antikoerper

Hintergrund:

Synonyms: ATS, GLUT10, Solute carrier family 2, facilitated glucose transporter member 10, Glucose transporter type 10, GLUT-10, SLC2A10

Background: Defects in SLC2A10 are the cause of arterial tortuosity syndrome (ATS) [MIM:208050]. ATS is an autosomal recessive disorder characterized by tortuosity and elongation of major arteries, often resulting in death at young age. Other typical features include aneurysms of large arteries and stenosis of the pulmonary artery, in association with facial features and several connective tissue manifestations such as soft skin and joint laxity. Histopathological findings include fragmentation of elastic fibers in the tunica media of large arteries.

Gen-ID: 81031

UniProt: O95528